YOLFTbeta
CH

Cheelcare Inc.

CHER · V · Healthcare / Medical Devices

1.31CAD-0.15 (-10.27%)

Price History

Full chart

Market Stats

Previous Close1.46
Open1.27
Day Range1.27 – 1.32
52-Week Range0.83 – 1.98
Volume3.65K
Market Cap34.32M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.14
Dividend Yield0.00%
Beta0.07
50-Day Avg1.50
200-Day Avg1.54

About

Cheelcare Inc. develops, manufactures, and distributes assistive mobility devices in the United States and Canada. It offers robotic complex rehab power wheelchairs, power add-ons for manual wheelchairs, and wheelchair accessories. The company was incorporated in 2015 and is based in Richmond Hill, Canada.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yevgeny Cherny
  • Employees19
  • Headquarters16 Sims Crescent, Richmond Hill, ON, Canada, L4B2P1, Canada
  • Websitehttps://www.cheelcare.com

Leadership

  • Mr. Yevgeny ChernyFounder & CEO, Director
  • Mr. Dmitry PaltsevFounder, Director & Corporate Secretary
  • Ms. Natasha Tsai C.A., C.P.A.Chief Financial Officer · b. 1981
  • Mr. Allex LaurinDirector of Marketing
  • Mr. Gennadiy LisnyakChief Mechanical Engineer
  • Dmitry MarukhDirector of Research & Development
  • Allan BoydVice President of Growth
  • Zach GreenProduction Coordinator
  • Mr. Eduard SominLead Software Engineer
  • Vladimir ChukharskySr Mechanical Engineer

Financials

Income Statement

Currency: CAD2023-04-302024-04-302025-04-302026-04-30
Total Revenue1.11M1.44M1.57M1.91M
Growth (%)-+29.47%+9.22%+21.60%
Cost of Revenue525.49K665.86K774.28K1.44M
Gross Profit584.67K771.45K795.61K464.52K
Gross Margin52.67%53.67%50.68%24.33%
Operating Expense705.14K1.33M2.12M2.81M
Operating Income-120.47K-556.50K-1.33M-2.34M
Operating Margin-10.85%-38.72%-84.44%-122.70%
EBITDA36.59K-350.92K-944.18K-4.22M
EBITDA Margin3.30%-24.42%-60.14%-221.19%
Net Income-120.47K-540.84K-1.27M-4.86M
Net Income Margin-10.85%-37.63%-80.90%-254.56%
R&D127.49K135.57K167.99K583.30K
R&D as % of Total Revenue11.48%9.43%10.70%30.56%
Interest Expense157.72K186.01K279.90K383.83K
Interest Expense % of Total Revenue14.21%12.94%17.83%20.11%

Balance Sheet

Currency: CAD2023-04-302024-04-302025-04-302026-04-30
Total Assets383.92K598.48K4.17M3.29M
Total Liabilities2.27M2.95M7.33M3.21M
Total Equity177.08K133.29K67.32K75.79K
Cash193.42K149.60K30.11K163.42K
Net Debt1.13M1.53M2.06M867.71K

Cash Flow

Currency: CAD2023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-78.58K-210.77K-495.94K-3.53M
Investing Cash Flow--2.27K-12.23K-
Financing Cash Flow272.00K241.21K4.00M442.30K
Capital Expenditure02.27K12.23K183.46K
Free Cash Flow-29.89K-213.04K-508.18K-3.72M
FCF to OCF38.03%101.08%102.47%105.19%

Earnings

Report DateSep 24, 2026Dec 30, 2026
EPS Estimate--
EPS Actual--
Surprise--
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap34.32M
Enterprise Value36.00M
Trailing P/E0.00
Forward P/E0.00
Price / Sales14.80
Price / Book446.81
EPS-0.14
Book Value0.004
Revenue (TTM)2.32M
Gross Profit (TTM)733.38K
EBITDA-2.51M
Profit Margin-160.83%
Operating Margin-52.77%
Return on Equity-189.10%
Return on Assets-39.07%
Shares Outstanding22.73M
Shares Float19.30M
Beta0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%